The role of genetic variants in CRP in radiographic severity in African Americans with early and established rheumatoid arthritis

[1]  A. Westfall,et al.  Comparison of the Disease Activity Score Using Erythrocyte Sedimentation Rate and C-reactive Protein in African Americans with Rheumatoid Arthritis , 2013, The Journal of Rheumatology.

[2]  A. Barton,et al.  Correlation of C-reactive protein haplotypes with serum C-reactive protein level and response to anti-tumor necrosis factor therapy in UK rheumatoid arthritis patients: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort , 2012, Arthritis Research & Therapy.

[3]  P. Gregersen,et al.  Studying associations between variants in TRAF1-C5 and TNFAIP3-OLIG3 and the progression of joint destruction in rheumatoid arthritis in multiple cohorts , 2012, Annals of the rheumatic diseases.

[4]  K. Steinsson,et al.  Genetic predisposition of the severity of joint destruction in rheumatoid arthritis: a population-based study , 2012, Annals of the rheumatic diseases.

[5]  Georg Schett,et al.  The pathogenesis of rheumatoid arthritis. , 2011, The New England journal of medicine.

[6]  M. Perola,et al.  CRP gene variation affects early development of Alzheimer's disease-related plaques , 2011, Journal of Neuroinflammation.

[7]  Chi-Jung Huang,et al.  Association of C-reactive Protein Gene Polymorphisms and Colorectal Cancer , 2011, Annals of Surgical Oncology.

[8]  T. Merriman,et al.  A Genetic Association Study of Serum Acute-Phase C-Reactive Protein Levels in Rheumatoid Arthritis: Implications for Clinical Interpretation , 2010, PLoS medicine.

[9]  C. Kessler,et al.  Genetic Variants in the C-Reactive Protein Gene Are Associated with Microangiopathic Ischemic Stroke , 2010, Cerebrovascular Diseases.

[10]  D. M. van der Heijde,et al.  Radiographic severity of Rheumatoid Arthritis in African Americans: Results from a multicenter observational study , 2010, Arthritis care & research.

[11]  Nathan Vastesaeger,et al.  A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis. , 2009, Rheumatology.

[12]  P. Gregersen,et al.  Association of a single-nucleotide polymorphism in CD40 with the rate of joint destruction in rheumatoid arthritis. , 2009, Arthritis and rheumatism.

[13]  M. González-Escribano,et al.  The Value of HLA-DRB1 Shared Epitope, −308 Tumor Necrosis Factor-α Gene Promoter Polymorphism, Rheumatoid Factor, Anti-Citrullinated Peptide Antibodies, and Early Erosions for Predicting Radiological Outcome in Recent-Onset Rheumatoid Arthritis , 2009, The Journal of Rheumatology.

[14]  J. Whittaker,et al.  Fine-mapping the genetic basis of CRP regulation in African Americans: a Bayesian approach , 2008, Human Genetics.

[15]  M. Petri,et al.  Genetic variation in the CRP promoter: association with systemic lupus erythematosus. , 2008, Human molecular genetics.

[16]  David Reich,et al.  The HLA-DRB1 shared epitope is associated with susceptibility to rheumatoid arthritis in African Americans through European genetic admixture. , 2008, Arthritis and rheumatism.

[17]  N. Kamatani,et al.  Associations between HLA-DRB1, RANK, RANKL, OPG, and IL-17 genotypes and disease severity phenotypes in Japanese patients with early rheumatoid arthritis , 2007, Clinical Rheumatology.

[18]  M. Soucek,et al.  Association of the 5A/6A Promoter Polymorphism of the MMP‐3 Gene with the Radiographic Progression of Rheumatoid Arthritis , 2007, Annals of the New York Academy of Sciences.

[19]  I. Marinou,et al.  Association of Interleukin-6 and Interleukin-10 Genotypes With Radiographic Damage in Rheumatoid Arthritis Is Dependent on Autoantibody Status , 2007, Arthritis and rheumatism.

[20]  D. M. van der Heijde,et al.  High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study , 2007, Annals of the rheumatic diseases.

[21]  C. Carlson,et al.  Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. , 2006, JAMA.

[22]  M. Rieder,et al.  Genetic Variation Is Associated With C-Reactive Protein Levels in the Third National Health and Nutrition Examination Survey , 2006, Circulation.

[23]  H. Paulus,et al.  ACR remission criteria and response criteria. , 2006, Clinical and experimental rheumatology.

[24]  G. Gilkeson,et al.  Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in African Americans with early rheumatoid arthritis. , 2006, Arthritis and rheumatism.

[25]  H. Yamanaka,et al.  Comparison of Disease Activity Score (DAS)28- erythrocyte sedimentation rate and DAS28- C-reactive protein threshold values , 2006, Annals of the rheumatic diseases.

[26]  M. Uffmann,et al.  Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease. , 2006, Rheumatology.

[27]  P. Lipsky,et al.  Association of the IL4R single-nucleotide polymorphism I50V with rapidly erosive rheumatoid arthritis. , 2006, Arthritis and rheumatism.

[28]  H. Paulus,et al.  Association of tumor necrosis factor α polymorphism, but not the shared epitope, with increased radiographic progression in a seropositive rheumatoid arthritis inception cohort , 2006 .

[29]  C. Carlson,et al.  Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. , 2005, American journal of human genetics.

[30]  D. Allison,et al.  Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level , 2005, Journal of Molecular Medicine.

[31]  Rodney X. Sturdivant,et al.  Applied Logistic Regression: Hosmer/Applied Logistic Regression , 2005 .

[32]  M. Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[33]  R. Detels,et al.  Analytical Performance of a Highly Sensitive C-Reactive Protein-Based Immunoassay and the Effects of Laboratory Variables on Levels of Protein in Blood , 2003, Clinical Diagnostic Laboratory Immunology.

[34]  F. Breedveld,et al.  Association of the -2849 interleukin-10 promoter polymorphism with autoantibody production and joint destruction in rheumatoid arthritis. , 2003, Arthritis and rheumatism.

[35]  Sidney C. Smith,et al.  MARKERS OF INFLAMMATION AND CARDIOVASCULAR DISEASE: APPLICATION TO CLINICAL AND PUBLIC HEALTH PRACTICE: A STATEMENT FOR HEALTHCARE PROFESSIONALS FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION AND THE AMERICAN HEART ASSOCIATION , 2003 .

[36]  F. Wolfe,et al.  The level of inflammation in rheumatoid arthritis is determined early and remains stable over the longterm course of the illness. , 2001, The Journal of rheumatology.

[37]  A. Silman,et al.  Combined sib-TDT and TDT provide evidence for linkage of the interleukin-1 gene cluster to erosive rheumatoid arthritis. , 1999, Human molecular genetics.

[38]  M. Ronaghi,et al.  A Sequencing Method Based on Real-Time Pyrophosphate , 1998, Science.

[39]  U. Wagner,et al.  HLA markers and prediction of clinical course and outcome in rheumatoid arthritis. , 1997, Arthritis and rheumatism.

[40]  S. Pillemer,et al.  HLA-DRB1 genes and disease severity in rheumatoid arthritis. The MIRA Trial Group. Minocycline in Rheumatoid Arthritis. , 1996, Arthritis and rheumatism.

[41]  A. Zwinderman,et al.  Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Results of a followup study. , 1991, Arthritis and rheumatism.

[42]  F. Arnett.  Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.

[43]  F. Stevenson,et al.  Comparison of serum and synovial fluid concentrations of beta 2-microglobulin and C reactive protein in relation to clinical disease activity and synovial inflammation in rheumatoid arthritis. , 1989, Annals of the rheumatic diseases.

[44]  B. Kubak,et al.  Binding sites for C-reactive protein on human monocytes are distinct from IgG Fc receptors. , 1989, Immunology.

[45]  H. Gewurz,et al.  Stimulation of human neutrophils, monocytes, and platelets by modified C-reactive protein (CRP) expressing a neoantigenic specificity , 1988, Inflammation.

[46]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[47]  D. Vergani,et al.  Correlation in rheumatoid arthritis of concentrations of plasma C3d, serum rheumatoid factor, immune complexes and C-reactive protein with each other and with clinical features of disease activity. , 1982, Clinical and experimental immunology.

[48]  H. Gewurz,et al.  INTERACTIONS OF C‐REACTIVE PROTEIN WITH LYMPHOID CELLS , 1982, Annals of the New York Academy of Sciences.

[49]  Hollis G. Potter,et al.  Author Manuscript , 2013 .

[50]  F. Breedveld,et al.  Minocycline in Rheumatoid Arthritis , 2012, Clinical Immunotherapeutics.

[51]  E. Siew,et al.  CRP polymorphisms and progression of chronic kidney disease in African Americans. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[52]  Vicente Bertomeu Martínez,et al.  Markers of Inflammation and Cardiovascular Disease , 2009, American journal of cardiovascular drugs : drugs, devices, and other interventions.

[53]  H. Paulus,et al.  Association of tumor necrosis factor alpha polymorphism, but not the shared epitope, with increased radiographic progression in a seropositive rheumatoid arthritis inception cohort. , 2006, Arthritis and rheumatism.

[54]  D. M. van der Heijde,et al.  How to read radiographs according to the Sharp/van der Heijde method. , 2000, The Journal of rheumatology.

[55]  D. M. van der Heijde,et al.  Open Access Research Article Association of Il4r Single-nucleotide Polymorphisms with Rheumatoid Nodules in African Americans with Rheumatoid Arthritis , 2022 .